Aquestive Therapeutics (NASDAQ:AQST) reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:00 PM.
Here’s what investors need to know about the announcement.
Earnings
Aquestive Therapeutics reported in-line EPS of $-0.36 versus an estimate of $-0.36.
Revenue was down $2.08 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.09 which was followed by a 3.65% increase in the share price the next day.
Here’s a look at Aquestive Therapeutics’s past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.41 | -0.47 | -0.45 | -0.44 |
| EPS Actual | -0.32 | -0.38 | -0.37 | -0.33 |
| Revenue Estimate | 10.11M | 9.36M | 11.01M | 9.48M |
| Revenue Actual | 12.27M | 11.08M | 13.29M | 15.35M |
To track all earnings releases for Aquestive Therapeutics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
